IGF2 and Wilms tumor: In summary, renal tumors developing in Wt1-Igf2 mice carry the same alterations that occur in human tumors, thus recapitulating the process of development and progression of Wilms tumor in human patients and providing a highly relevant model for testing new molecular targeted therapies.